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Abstract 27 
Background: Exercise referral schemes are recommended by the National Institute for 28 
Clinical Excellence (NICE) for physical activity promotion among inactive patients with 29 
health conditions or risk factors. Whilst there is evidence for the initial effectiveness and 30 
cost-effectiveness of such schemes for increasing physical activity, evidence of long-term 31 
effects is limited. Techniques such as goal setting, self-monitoring and personalised feedback 32 
may support motivation for physical activity. Technologies such as activity monitoring 33 
devices provide an opportunity to enhance delivery of motivational techniques. This paper 34 
describes the PACERS study protocol, which aims to assess the feasibility and acceptability 35 
of implementing an activity monitor within the existing Welsh National Exercise Referral 36 
Scheme (NERS) and proposed evaluation methodology for a full-scale randomised controlled 37 
trial.  38 
Methods/Design: The PACERS study consists of a pilot randomised controlled trial, process 39 
evaluation and exploratory economic analyses. Participants will be recruited from the generic 40 
pathway of the Welsh NERS and will be randomly assigned to receive the intervention or 41 
usual practice. Usual practice is a 16-week structured exercise programme, the intervention 42 
consists of an accelerometry-based activity monitor (MyWellnessKey) and an associated web 43 
platform (MyWellnessCloud). The primary outcomes are predefined progression criteria 44 
assessing the acceptability and feasibility of the intervention and feasibility of the proposed 45 
evaluation methodology. Postal questionnaires will be completed at baseline (time 0: T0), 16 46 
weeks after T0 (T1), and 12 months after T0 (T2). Routinely collected data will also be 47 
accessed at the same time points. A subsample of intervention participants and exercise 48 
referral staff will be interviewed following initiation of intervention delivery and at the end of 49 
the study.  50 
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Discussion: The PACERS study seeks to assess the feasibility of adding a novel motivational 51 
component to an existing effective intervention in order to enhance effects on physical 52 
activity and support longer-term maintenance. The study will provide insight into the 53 
acceptability of activity monitoring technologies to an exercise referral population and 54 
delivery staff. Data from this study will be used to determine whether and how to proceed to 55 
a full-scale trial of effectiveness of the intervention, including any necessary refinements to 56 
intervention implementation or the proposed evaluation methodology.  57 
 58 
Trial registration:  59 
ISRCTN85785652 60 
 61 
Keywords:  62 
Exercise referral, Physical activity, Autonomous motivation, Feasibility studies, 63 
Accelerometer/try, Physical activity monitors, Physical activity trackers, Costs, Economic 64 
evaluation 65 
 66 
Background  67 
Physical inactivity is a major cause of preventable illness with large costs to the National 68 
Health Service (NHS) [1]. Increasing activity at the population level and among at-risk 69 
groups is a public health priority [2, 3]. Physical activity interventions for at-risk groups often 70 
involve advice and/or signposting from primary care practitioners [4]. Exercise referral 71 
schemes (ERS) are one common model [5], usually involving referral to a community-based 72 
structured exercise program. In Wales, the 16-week National Exercise Referral Scheme 73 
(NERS) has been running since 2007. A previous effectiveness study of the scheme [6] 74 
showed that, at 12 months, NERS was associated with improvements in physical activity for 75 
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patients at risk of coronary heart disease, but not for those referred for anxiety and 76 
depression, despite an improvement in their mental health [7]. The evaluation also showed 77 
the base-case incremental cost-effectiveness ratio was £12,111 per quality adjusted life year 78 
(QALY), falling to £9741 if participants were to contribute £2 per session [7]. Qualitative 79 
data highlighted a need for post-intervention motivational support to maintain changes [7, 8]. 80 
Whilst there is evidence for effectiveness of ERS in increasing physical activity in the short-81 
term [9-11] evidence of long-term effects is limited. The Department of Health’s Quality 82 
Assurance Framework for Exercise Referral [12] highlights the need to understand how to 83 
support long-term maintenance of changes in physical activity.  84 
 85 
On entry to an ERS, patients may be initially motivated by external sources such as GP 86 
advice to attend [13, 14]. However, sustained changes in physical activity are consistently 87 
associated with more internalised, or autonomous, motivation [15-17]. According to Self-88 
Determination Theory [18], the development of autonomous motivation can be achieved 89 
through supporting psychological needs for autonomy (volitional and self-endorsed 90 
engagement), competence (personal mastery and effectiveness) and relatedness (meaningful 91 
interpersonal connections).  Thus, developing ways to support these three needs should help 92 
to maintain changes in physical activity.  Support for this notion is provided by the 93 
randomised controlled trial of the Welsh NERS which found increases in autonomous 94 
motivation after scheme exit. This increase explained almost half of the between group 95 
difference in physical activity six months later [19]. Integrating processes to further enhance 96 
and sustain autonomous motivation during and after involvement in an exercise referral 97 
scheme may lead to larger effects and longer-term maintenance of these. Existing evidence 98 
points to potential motivational effects of techniques such as goal setting, monitoring, and 99 
personalised feedback on progress towards goals [20, 21] which may support autonomous 100 
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motivation by enhancing patients’ sense of mastery and competence andare recommended by 101 
NICE as core components of behaviour change interventions [22].  102 
 103 
Technologies such as activity monitors, provide opportunities to enhance delivery of goal 104 
setting and feedback, allowing for more frequent, and automatic feedback on progress toward 105 
activity goals, tailored updating of goals based on achievement, and remote contact with 106 
intervention providers [23]. In addition to addressing psychological needs for competence, 107 
incorporation of social components may support motivation through promoting relatedness to 108 
other service users. Research on such technologies in exercise interventions suggests that use 109 
can be quickly integrated in participants’ lives [24] and may increase physical activity levels 110 
[25-29], however overall the evidence is equivocal [23]. Furthermore, little is known about 111 
the acceptability of these technologies to ERS populations or if the benefits will remain once 112 
the initial novelty has ceased. Exercise referral patients are a diverse group with a range of 113 
ages and conditions. For example, although the average age of participants in the evaluation 114 
of the Welsh NERS was 52 years old, the overall ages ranged from 16 to 88. Thus, familiarity 115 
with technology and willingness to use it may differ within the group [30]. In addition, 116 
participant diversity in terms of socioeconomic status and geographic location may result in 117 
differences in access to high speed internet connections or the hardware required for 118 
engaging with some technologies (e.g. personal computer). Hence, prior to a trial of 119 
effectiveness, which may be undermined by difficulties integrating technologies into routine 120 
practice or facilitating uptake by patients, piloting is required to investigate these issues.  121 
 122 
A preliminary investigation [31] tested a protocol for integrating activity monitoring devices 123 
(MyWellnessKey, Technogym) and a linked web platform in one local authority area of the 124 
Welsh NERS. The study showed potential for using the MyWellnessKey (MWK) devices in 125 
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the scheme; however, further work is required to understand the feasibility and acceptability 126 
of this on a larger scale with a demographically diverse population. In this paper we describe 127 
the protocol of the PACERS study, a pilot trial to assess the feasibility and acceptability of 128 
using the MWK activity monitors to promote maintenance of physical activity within NERS. 129 
The aim of the study is to evaluate the feasibility and acceptability of the intervention (the 130 
MWK) and its proposed evaluation methodology, in order to optimise design and delivery 131 
and evaluate whether a full scale randomised controlled trial of effectiveness is warranted and 132 
feasible. 133 
 134 
Study aim 135 
The primary aim of the study is the assess the feasibility and acceptability of implementing 136 
the MWK activity monitors within the Welsh NERS as well as the proposed evaluation 137 
methodology in order to optimise design and delivery for conducting a definitive evaluation 138 
trial.  139 
 140 
Study objectives 141 
The main objectives for this study are to investigate:  142 
a) the fidelity of delivery of the intervention and trial methodology including compliance 143 
with study invitation and randomisation processes; 144 
b) the acceptability of the intervention to participants in terms of its usability and 145 
likelihood of future use; 146 
c)  whether randomisation is acceptable to 50% or more of to participants;  147 
d) the feasibility of recruiting 20% or more new NERS patients and retaining at least 148 
80% of participants at 12-month follow-up (T2);  149 
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e) contamination, by exploring whether less than 20% of control participants are the 150 
exposed to the intervention;   151 
f) the effect of the intervention on the main hypothesised change mechanism 152 
(autonomous motivation); 153 
g) the feasibility of collecting the primary, secondary and process outcome measures and 154 
economic evaluation methods.  155 
 156 
Methods 157 
Study design 158 
The study design is an individually randomised pilot randomised controlled trial, plus a 159 
process evaluation and exploratory economic analyses, of implementing the MWK devices 160 
within Welsh NERS standard practice. Data will be collected at three time points: baseline 161 
(time 0 (T0)), at the end of the 16-week NERS programme (T1) and 12-months post-baseline 162 
(T2). Figure 1 shows the study flow diagram. The study was given favourable ethical opinion 163 
for conduct in the NHS on 1st December 2015 by the South East Scotland Research Ethics 164 
Committee 02 (REF: 189587).  165 
 166 
Figure. 1 Flow diagram of the PACERS study design 167 
 168 
Setting and participants 169 
The study is being undertaken within the Welsh NERS across leisure centres in eight local 170 
authority areas in Wales, UK.  The eight study sites were purposively selected to reflect a 171 
range of urbanisation and geography. Participants are eligible for the study if they; i) are 172 
referred into the NERS generic pathway (see Box 1), and ii) have the capacity to use the 173 
activity monitors (i.e. computer access and an email address). 174 
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 188 
Recruitment  189 
Participants will be recruited to the trial using opportunistic invites within the existing 190 
scheme structure. NERS exercise professionals will provide information about the study to all 191 
new generic pathway clients during their first consultation appointment on the scheme. 192 
Exercise professionals will transfer the contact details of clients who are eligible for and 193 
interested in joining the study to the research team using a secure electronic form. The 194 
research team will send a recruitment pack containing full informed consent materials and the 195 
baseline questionnaire to interested clients to be returned by post. Participants who return a 196 
signed consent form and completed baseline questionnaire will be entered into randomisation. 197 
Participants in the intervention group will be sent information about the process evaluation 198 
interviews following randomisation and will be asked to express an interest in taking part in 199 
Box 1. NERS Generic Pathway Criteria 
For referral into the NERS generic pathway, patients must:  
- be aged 16 years or above;  
- be sedentary (defined as not moderately active for 3 times per week or 
deconditioned through age or inactivity); 
- have at least one of the following: 
o Raised blood pressure 140/90,  
o BMI >28,  
o Cholesterol >5.0,  
o Controlled diabetes or impaired glucose intolerance,  
o Family history of heart disease or diabetes,  
o At risk of osteoporosis and/or musculoskeletal pain,  
o Mild arthritis or poor mobility,  
o Mild-moderate COPD, asthma, bronchitis, emphysema,  
o Mild anxiety, depression or stress,  
o Multiple sclerosis.  
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the interviews. From those who express an interest, participants will be selected to provide 200 
variation in local authority area, age, sex, and reason for referral. Where possible we will 201 
interview the same participants at 4-weeks and 12-months. Where not possible, additional 202 
participants matched by demographics (e.g. age and sex) will be recruited for 12-month 203 
interviews. All NERS staff involved in the study will be invited to participate in the process 204 
evaluation interviews. From those who express an interest, two staff members per local 205 
authority area will be selected.    206 
 207 
Randomisation 208 
After completion of baseline measures, study staff will randomly assign participants 1:1 to 209 
receive either the intervention (NERS plus MWK) or the control treatment (NERS standard 210 
practice) via a computer-generated random allocation sequence created by the South East 211 
Wales Trials Unit.  212 
 213 
The Intervention  214 
Box 2. Features of the MWK activity monitor and MyWellnessCloud web platform  
 Real-time visual feedback via a screen on the activity monitor   Detailed feedback on activity levels via a web platform to indicate progress 
towards goals, time spent in different activity intensities and calories burned   Automatised goal setting via an algorithm which sets goals in a stepwise fashion 
such that forward progression is mastery-based   Facilitation of social support for exercise via the web platform (through 
involvement in group challenges and remote communication with an exercise 
professional) and smartphone app (the option to share details about activity 
completed via social media)   Free access to the web platform and smartphone application following 
discontinuation of use of the MWK via manual input or by linking the account to 
another monitoring device.  
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The intervention is an enhanced ERS that includes usual care (NERS standard practice) [6] 215 
plus an accelorometry-based activity monitor (MyWellnessKey; MWK). The MWK can be 216 
used for self-monitoring of physical activity levels in combination with a linked web platform 217 
(MyWellnessCloud) and smartphone application (see box 2). The MWK has been validated 218 
in terms of device accuracy at monitoring physical activity level and intensity [32, 33] and 219 
utility at fostering increased physical activity levels (high concurrent validity with ActiGraph 220 
accelerometer to detect physical activity in laboratory and free living environments) [34].  221 
Intervention participants will be provided with a MWK to use for the remaining 12 weeks of 222 
their 16-week NERS programme after receiving it at their 4-week consultation and will be 223 
encouraged to use it for 36 weeks after they exit the scheme, up until their 12-month 224 
consultation when the device will be returned. In current practice conducting an 8-month 225 
telephone consultation to check clients’ progress with exercise is an optional part of standard 226 
care. To encourage participants to maintain engagement in the study we have asked for the 227 
telephone consultation to take place with all intervention participants. Table 1 shows how the 228 
intervention will be implemented within the scheme.  229 
 230 
It is anticipated that the intervention will enhance NERS through two key mechanisms; 1) 231 
goal setting and personalised feedback elements of the devices will support a sense of 232 
exercise mastery and perceived competence; 2) the web platform will provide a sense of 233 
relatedness to others via opportunities to communicate remotely with exercise professionals, 234 
other NERS clients and social media contacts. It is anticipated that these mechanisms will 235 
improve autonomous motivation for exercise, leading to greater maintenance of increases in 236 
physical activity, as depicted in the intervention logic model (see Figure 2).  237 
 238 
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Figure 2. PACERS logic model 239 
 240 
Control treatment 241 
Control participants will receive usual care which is NERS standard practice; a 16-week 242 
structured exercise programme which includes consultations with an exercise professional at 243 
the start, 4-weeks, on exiting the scheme (16-weeks) and at 12-month follow-up [6].   244 
 245 
Primary outcome 246 
The primary outcome will be the feasibility and acceptability of the intervention and its 247 
proposed evaluation methodology, to inform a decision on whether a full randomised 248 
controlled trial is warranted and feasible. This will be assessed against a set of predefined 249 
progression criteria related to recruitment and retention rates, exposure to the intervention in 250 
both intervention and control groups, and acceptability of the intervention, recruitment and 251 
randomisation processes to participants. The criteria were agreed by the Trial Steering 252 
Committee (TSC) and follow a traffic light assessment system (red=stop; amber=discuss with 253 
TSC whether there is enough evidence that sufficient improvements can be made to proceed 254 
to full trial without another feasibility assessment; green=proceed) using quantitative 255 
measures supported by qualitative data. The criteria, their measurement, and assessment 256 
criteria are summarised in Table 2. Qualitative data will provide insights into intervention and 257 
evaluation design features which need to be retained, or where metrics fall into the amber 258 
zone, modifications which may need to be made to improve feasibility and acceptability.  259 
 260 
It is anticipated that in a full trial, the main outcome measure will be objectively measured 261 
physical activity using accelerometry. To examine the feasibility of collecting this data at 262 
follow-up in the NERS population, a sub sample of participants will be recruited to complete 263 
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the accelerometer measure at 16 months post-randomisation. Participants will wear a GT3X 264 
ActiGraph accelerometer around the waist for seven consecutive days during waking hours. 265 
Data will be processed to identify mean minutes of moderate to vigorous intensity activity per 266 
day and mean accelerometer counts per minute (volume of physical activity) using 267 
established processes [35].   268 
 269 
Secondary outcomes  270 
The effect of the intervention on the main hypothesised change mechanism (autonomous 271 
motivation) will be evaluated. Other secondary outcome measures will be piloted to estimate 272 
key trial parameters (e.g. standard deviation) to inform a future full trial.  273 
 274 
Measures collected routinely in NERS  275 
Data collected routinely within NERS will be obtained for use within the trial from T0, T1 276 
and T2, as follows:  277 
 Blood pressure and resting heart rate;  278 
 Body Mass Index;  279 
 Waist circumference;  280 
 Self-reported physical activity (Scottish Physical Activity Questionnaire) [36];  281 
 Health-related quality of life (EQ-5D-5L) [37]; 282 
 Fitness test (Chester fitness test) [38].  283 
 284 
Measures included in PACERS study questionnaire 285 
The following additional measures will be collected at all time-points, which in a full trial 286 
would be used to assess effectiveness of the added intervention component 287 
(MyWellnessKey): 288 
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  Autonomous Motivation (Behavioural Regulation in Exercise Questionnaire 3 289 
(BREQ-3)) [39]; 290 
 Psychological need support (Intrinsic Motivation Inventory) [40]; 291 
 Anxiety and depression (Hospital Anxiety and Depression Scale (HADS)) [41].  292 
 293 
Economic evaluation outcome measures 294 
The PACERS study questionnaire will include an adapted Client Service Receipt Inventory 295 
(CSRI) based on the previous service use questionnaire used in the NERS evaluation [7] and  296 
examples in the DIRUM database (dirum.org) to capture client health and social care service 297 
use since the last time point (plus a four month retrospective period at baseline). Additional 298 
questions in the 12-month questionnaire will capture wider economic outcomes including 299 
current work status, days off work due to health problems and estimated income lost due to 300 
changes in work during the study period. Willingness to pay for the MWK will also be 301 
explored. Baseline demographic data on housing status and household income will also be 302 
collected in the PACERS study questionnaire for the purpose of the economic analysis. 303 
 304 
Sample size 305 
The proposed sample size for the study of 286 participants was calculated to allow the 306 
estimation of the feasibility proportions of adherence and retention to within at least plus or 307 
minus 8.2 percentage points using a 95% confidence interval, as well as to provide 80% 308 
power to detect an effect size of 0.4 at the 5% level on the main hypothesised mediator of 309 
autonomous motivation at 12-month follow-up, assuming 30% attrition [7]. The sample size 310 
was also planned to provide an indication of likely response rates, permit estimates of effect 311 
sizes of primary and secondary outcomes in advance of a larger trial, and allow exploration of 312 
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socio-demographic patterning in uptake and use of the MWKs in order to generate 313 
hypotheses regarding who the intervention might work for and why.  314 
 315 
Data collection  316 
Routinely collected data will be extracted from the NERS database at all T0, T1 and T2. The 317 
PACERS study questionnaire will be mailed to participants at all time-points. Telephone and 318 
email reminders will be made to non-responders. Semi-structured telephone interviews will 319 
be conducted with a sub-sample of intervention participants (n=20) following receipt of the 320 
intervention at 4-weeks and again at 12-months (T2) to explore feasibility and acceptability 321 
of the intervention and study methods. In addition, telephone interviews will be conducted 322 
with a sample of NERS exercise professionals at the same time points to explore feasibility 323 
and acceptability of implementing the intervention and study methods from a professional 324 
perspective.  Figure 3 indicates the schedule of enrolment, interventions and assessments.  325 
 326 
Figure 3. PACERS study schedule of enrolment, interventions, and assessments. 327 
 328 
Process evaluation  329 
A detailed process evaluation will examine the acceptability and feasibility of the 330 
intervention and evaluation methods, including intervention delivery and fidelity, potential 331 
contamination and contextual influences. Quantitative and qualitative data will be collected 332 
using a range of methods. Table 3 summarises the process evaluation methods.  333 
 334 
Economic analysis methods 335 
Data will be collected to estimate intervention costs and examine the feasibility of calculating 336 
cost-effectiveness alongside a definitive full pragmatic randomised trial. Health care service 337 
use will be costed using national unit costs  [42, 43]. Both arms of the study with be costed, 338 
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revisiting and revising the costing methodology used in previous economic analysis of the 339 
Welsh NERS [44]. 340 
 341 
The additional costs of the intervention will consist of: the cost of the MWK; staff costs 342 
relating to the MWK (e.g. training, implementation and participant follow up support); the 343 
cost of the professional web cloud (e.g. licence fee) and additional staff interactions. These 344 
costs are in addition to the core programme costs (in both arms) including: NERS standard 345 
practice costs and participant contributions. Information about the additional staff resources 346 
required for the use of the MWK and professional web cloud will be derived from qualitative 347 
interviews with staff.  348 
 349 
Data analysis  350 
Quantitative analysis 351 
The main outcomes in this feasibility study are related to the study progression criteria as 352 
outlined in Table 2. The methods of analysis for quantitative data collected for the process 353 
evaluation are summarised in Table 3. Analyses will be largely descriptive, with summary 354 
statistics being presented overall and also by key demographics. Evidence of whether the 355 
intervention could lead to behaviour change will be examined using regression analyses to 356 
quantify effects on autonomous motivation, using the Relative Autonomy Index derived 357 
from the BREQ-3.  358 
 359 
To examine the direction of effect on physical activity Analysis of Covariance models 360 
[ANCOVA] will be used to estimate intervention effects on physical activity at 16 months. 361 
While likely non-significant due to limited power, this should be in the direction of a 362 
favourable intervention effect. Accelerometer data will be processed using standard 363 
procedures; periods of ≥ 60 minutes of zero counts will be recorded as “non-wear time” and 364 
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removed. Participants will be included in the analysis if they provide ≥ 3 valid days (i.e. 500 365 
minutes of data between 6am and 11pm). Mean minutes of daily moderate to vigorous 366 
intensity activity will be estimated using a threshold value of ≥2020 counts per minute with 367 
minutes of light intensity physical activity estimated using thresholds of between 100 and 368 
2019 counts per minute [35]. Sedentary time will be estimated based on a cut-point of less 369 
than 100 counts per minute; mean sedentary minutes per day will be derived.  370 
 371 
Qualitative analysis 372 
Qualitative data from interviews with exercise professionals and intervention participants will 373 
be transcribed verbatim and organised and coded into a thematic framework using NVivo 11 374 
software.  An approach to thematic analysis will be used that allows for both a deductive and 375 
inductive approach to data analysis [45]. Data will be initially coded using an a priori coding 376 
scheme of categories which align with the research questions as a means of organising the 377 
data for subsequent interpretation. An element of flexibility will be maintained to account for 378 
the emergence of any new and unexpected themes. The first three transcripts will be 379 
independently coded by two coders in order to develop a shared codebook via consensus. 380 
Any disagreements between coders will be discussed with a third coder. Divergence and 381 
convergence between interviews will be examined and comparisons made of the experiences 382 
of the intervention across and within areas (NERS clients and exercise professionals). We 383 
aim to develop a comprehensive understanding of the intervention acceptability, 384 
implementation and mechanisms of impact.  385 
 386 
Economic Analysis  387 
A pilot cost-consequence analysis will be conducted from a NHS and societal perspective. 388 
Response rates and level of completion of the measures will be reported using descriptive 389 
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statistics. Variables will be checked for out of range values before analysis begins. As data 390 
are expected to be skewed, non-parametric tests will be used to assess differences across 391 
groups or time points for the outcomes of QALYs (using the EQ-5D) and health and social 392 
care service use. We will bootstrap (5,000 replications) differences in cost and outcomes to 393 
produce a 95% confidence interval around these differences. Ceiling effects on the EQ-5D 394 
will also be assessed, assessing the proportion of participants that state “no problems” on all 395 
five dimensions on the EQ-5D questionnaire. QALY gains (using the EQ-5D) will be 396 
compared to those in similar samples from previous literature (where available).   397 
 398 
A report on the data gathered about service use (from routinely collected data recorded by 399 
healthcare professionals delivering NERS) will explore if future studies could use this or a 400 
different method to the CSRI questionnaire used in the feasibility study. Descriptive statistics 401 
will be used to describe the amount participants are willing to pay for the MWK, both during 402 
the intervention and beyond. Response rates and level of completion of the questions 403 
exploring how best to capture productivity losses will be reported using descriptive statistics.  404 
Sub-group analyses will explore the effect on health related quality of life of socio-405 
demographics (e.g. gender) and reason for referral. Sensitivity analysis will be conducted in 406 
accordance with NICE guidelines to vary the cost of the device [46], demonstrating what 407 
happened in the feasibility trial and how co-ordination may be varied in a future full-scale 408 
trial.  409 
 410 
Serious adverse event reporting and monitoring 411 
It is not anticipated that there will be any additional risks to participants over and above 412 
existing NERS standard practice for which standard operating procedures are in place 413 
covering referral into the scheme, provision of exercise instruction and support, and dealing 414 
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with adverse events. There are no serious adverse events expected to be related to the 415 
intervention. Any serious adverse event occurrence will be reported to the Chief Investigator 416 
within 48 hours of receiving notification. Assignment of causality will be made by the 417 
independent clinician member of the TSC.  418 
 419 
Project management 420 
A Trial Management Group is responsible for ensuring the appropriate, effective and timely 421 
implementation of the trial including monitoring adherence to standardised research 422 
protocols. The day-to-day operational management of the feasibility study is co-ordinated by 423 
a central project management team which meets weekly to monitor progress and any issues 424 
which may need relaying to the Trial Management Group. An independent TSC provides 425 
overall supervision for the trial and advice through its independent chair and also 426 
encompasses the role of Data Monitoring Committee.  427 
 428 
Discussion 429 
The PACERS feasibility trial aims to assess the feasibility and acceptability of implementing 430 
a novel motivational component, the MyWellnessKey, into the existing Welsh NERS. In 431 
addition, the trial also aims to determine the acceptability and feasibility of the proposed 432 
evaluation methodology for a definitive trial of the intervention for promoting long-term 433 
maintenance of physical activity. Whilst exercise referral approaches have been shown to be 434 
effective for increasing physical activity levels, evidence of long-term effects is limited [9, 435 
10, 12] and so there is a need to better understand how to support long-term maintenance of 436 
physical activity [3]. The MWK intervention offers a potential mechanism for enhancing and 437 
sustaining autonomous motivation for physical activity via evidence-based techniques 438 
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including goal setting, self-monitoring and receiving personalised feedback on progress 439 
towards goals [20-22].  440 
 441 
Findings from this study will determine whether progression to a full scale randomised 442 
controlled trial of effectiveness and cost-effectiveness is feasible and warranted, through the 443 
assessment of key progression criteria. The study will assess whether the outcomes being 444 
used are feasible and acceptable to use with the study population. Findings related to the 445 
acceptability and feasibility of implementing the intervention will inform potential refinement 446 
of the implementation processes where necessary. The findings will also allow refinement of 447 
the intervention logic model.  448 
 449 
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Figure titles and legends 635 
Figure 1. Flow diagram of the PACERS study design. (page 8) 636 
 637 
Figure 2. PACERS logic model. (page 11) 638 
 639 
Figure 3. PACERS study schedule of enrolment, interventions, and assessments. (page 14) 640 
X = study participants, X = intervention delivery staff641 
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Table 1.  Implementation of the intervention components 
Time-point Exercise professionals Intervention participants 
At 4 week review 
appointment 
Set up participants with a 
MWC account, configure 
initial activity goals on the 
MWK and demonstrate how 
to use the device and web 
platform. 
Take the MWK home, sign into their 
MWC account on their home 
computer and connect their MWK to 
read data and charge it.  
Over the study 
period (48Weeks) 
Interact with participants to 
monitor and adjust their 
goals, send positive 
comments and set up group 
challenges through direct 
messaging via a linked 
website called Professional 
Cloud.  
Use the device daily and connect the 
MWK to a computer at least twice per 
week to upload data to the MWC, 
receive feedback and charge the 
device.  
Manually enter information about 
activity that the device does not 
readily measure, i.e. swimming, 
weight training, cycling. 
At 8 months from 
start  
Telephone participants to 
check on their progress with 
exercising and remind them 
of the study and encourage 
use of the MWK, MWC and 
associated features.  
Participants with a MWK continue to 
use it daily. 
At 12 months 
from start 
Exercise professionals will 
have a consultation with all 
Hand the MWK back to the exercise 
professional. 
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participants for usual NERS 
assessments and to collect the 
MWK. 
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Table 2 Summary of progression criteria  
Progression 
Criteria (PC) 
Measures used 
Assessment of whether criteria have 
been met 
PC1. Feasibility to 
recruit a sufficient 
proportion of new 
NERS patients to 
participate in the 
trial, with 
appropriate 
retention rates to 12 
month follow-up.  
 The percentage of new NERS patients 
recruited to the trial, and retained at 
each subsequent follow-up.  
 Regression models will be used to 
identify predictors of loss to follow-up 
(e.g. demographics or baseline 
motivation). 
 If >20% of new NERS patients recruited 
= proceed; if <5% = full-scale trial 
unlikely to be feasible. If 5-20% the TSC 
will consider the feasibility of proceeding 
to a full-scale trial bearing in mind the 
data and feedback presented and 
representativeness of the recruited 
sample, and possible steps to increase the 
recruitment rate. 
 If >80% retained at 12-months = proceed, 
if <60% = full-scale trial unlikely to be 
feasible. If 60-80% the TSC will consider 
the feasibility of proceeding based on the 
available data and possible steps to 
increase retention. 
PC2. Intervention 
and trial 
methodology 
delivered as 
intended 
 Summary statistics for intervention 
fidelity measures overall and by area.  
 Compliance with study invite 
processes. 
 Compliance with randomisation 
processes.  
 The TSC will consider the data presented 
and make a judgement about whether the 
intervention and trial methodology were 
delivered as intended. 
PC3. At least one 
of the two 
intervention 
 Percentages of participants who report 
acceptability of the intervention 
components on four self-report 
 The TSC will consider the quantitative 
and qualitative data and make an overall 
judgement on whether the intervention is 
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components is 
acceptable to 
participants  
 
questions. 
 Issues regarding acceptability of, and 
engagement with, the two intervention 
components explored in qualitative 
interviews with a sub-sample of 
intervention participants.  
acceptable. 
PC4. Recruitment 
and randomisation 
processes 
acceptable to >50% 
of recruited 
participants  
 
 Percentages of participants who report 
acceptability of the recruitment and 
randomisation processes on patient 
questionnaires.  
 Exploration of understanding and 
acceptability of recruitment and 
randomisation processes in qualitative 
interviews.  
 >50% of recruited participants report 
‘agree’ or ‘strongly agree’ to questions 
about the acceptability of recruitment and 
randomisation processes. 
 The TSC will apply discretion in judging 
whether this criterion has been met, or 
could be addressed to improve 
acceptability in a full-scale trial. 
PC5. < 20% of 
control group 
exposed to the 
intervention 
components 
 
 The percentage of participants in 
intervention and control groups who 
report that they were provided with a 
MWK device or accessed the MWC 
web platform. 
 <20% of control participants report that 
they have used a MWK device during the 
study period. 
 <20% of control participants report that 
they have accessed the MWC during the 
study period. 
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Table 3. Summary of process evaluation methods 
Fidelity/Feasibility/  
Acceptability 
Method of data collection Aims to explore Method of Analysis  / Data to be presented Participants  Time 
Fidelity to trial 
methodology (PC2) 
Audio recordings of NERS 
initial consultations with 
participants 
The accuracy with which 
recruitment and consent 
processes were followed. 
A summary score of adherence to the 
processes (range 0-4) will be calculated for 
each recording and presented overall and by 
area 
Two participants 
per exercise 
professional  
T0 (during NERS  
initial 
consultation) 
Feasibility of 
implementing the 
intervention and trial 
methodology within 
routine NERS 
practice  
Telephone interviews with 
NERS staff  
 
 
 
Barriers/ facilitators, fit 
with local context, any 
adverse effects on usual 
NERS delivery, 
differences across 
settings, additional 
infrastructure or resources 
required for a full trial.  
Thematic analysis 
 
 
 
Two exercise 
professionals 
per area  
After receipt of 
the intervention at 
4-weeks and at T2 
Acceptability of the 
trial methodology 
(PC4) 
Telephone interviews with 
NERS staff and 
intervention participants  
 
 
Self-report questions on 
study questionnaire 
Understandings and 
acceptability of 
recruitment and 
randomisation processes. 
Thematic analysis 
 
 
 
 
Percentages of participants reporting 
acceptability of the randomisation process 
Two exercise 
professionals 
per area, 20 
intervention 
participants 
 
All participants 
After receipt of 
the intervention at 
4-weeks and at T2 
 
 
 
T1 
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Acceptability of the 
intervention (PC3) 
Telephone interviews with 
professionals and 
participants patients  
Perceived acceptability of 
intervention components, 
barriers and facilitators in 
using the devices. 
 
Thematic analysis Two exercise 
professionals 
per area, 20 
intervention 
participants 
After receipt of 
the intervention at 
4-weeks and at T2 
 Self-report questions on 
study questionnaire  
Frequency of use, ease of 
use, likelihood of future 
use.  
Percentages of participants reporting that the 
intervention was easy to use, that they used 
it, and would do so in the future  
All intervention 
participants 
T1 and T2 
Feasibility of 
collecting objective 
data on physical 
activity at long-term 
follow up 
ActiGraph accelerometers The feasibility of 
obtaining measures of 
physical activity over a 7 
day period 
A linear regression model controlling for age, 
gender, baseline self-reported physical 
activity and randomisation group will be 
fitted. Results will be expressed using 
regression coefficients, 95% confidence 
intervals, and standardised effect sizes.  
100 participants 16 months post-
randomisation 
Contamination 
(PC5)                        
Self-report questions on 
study questionnaire on 
awareness of and exposure 
to intervention components  
 
Assessment of 
contamination between 
trial arms. 
Percentages of participants in intervention 
and control arms reporting exposure to the 
intervention will be presented alongside 95% 
confidence intervals.  
All participants T1 and T2 
